PubMed Health⌕ Search

PubMed · 12651456

Comparing light interception with stand basal area for predicting tree growth.

Abstract

Empirical and process-based tree growth models have been developedconcurrently; however, their growth predictions have rarely been compared directly. A major difference between the model types is the explicit quantification of foliage biomass as a key variable in process-based models. The aim of this work was to test if this difference has a significant impact on model behavior, especially when simulating silvicultural practices such as intensive thinning. A method was developed to evaluate leaf area and light interception of the mean tree of an even-aged stand from yield table data for Norway spruce (Picea abies (L.) Karst.) in the northern French Alps. Two scenarios were analyzed: (1) a closed stand where leaf area was limited by a maximum leaf area index-represented by young, dense stands, and (2) an open stand where leaf area was limited by the height of the crown base-represented by old, sparse stands. Light interception was calculated based on interpolation between a closed stand (Beer-Lambert law) and an isolated tree (light interception proportional to leaf area). This approach was then used to build a growth model in which competition was described by the ratio of light intercepted by a mean tree of the stand to light intercepted by an isolated tree of the same size. This process-based model was compared with a simpler empirical model in which competition was described by stand basal area. Both models fit well to yield table diameter increment data, the simpler model being slightly better. Simulation of long-term growth, interspersed with thinning, revealed differences between the models. The empirical model was sensitive to thinning and simulated a discontinuous growth pattern, whereas the model based on light calculation showed a smoother growth response to thinning. Simulations of heavy thinning in a dense stand highlighted these differences. The empirical model simulated heavy thinning in a dense stand unrealistically: after thinning, trees immediately grew as fast as trees of similar diameter in an unthinned stand at the same density. In contrast, leaf area played a regulatory role in the model based on light interception: trees with short crowns, as a result of a previous period of growth at high density, benefited little from an increase in light following thinning. It is concluded that models based on physiological or ecological processes have qualitative behaviors different from those of classical empirical models. This is especially important when models are used to make extrapolations far from reference data, for example, to forecast the long-term effect of a new silvicultural strategy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Benoît Courbaud. 2000. Comparing light interception with stand basal area for predicting tree growth.. https://doi.org/10.1093/treephys%2F20.5-6.407

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗